Pharma companies may feel heat of US tariffs on China

India's pharmaceutical industry is bracing for potential disruptions due to US tariffs on Chinese goods. Experts warn that China may increase prices for key pharmaceutical ingredients exported to India to offset tariff costs. With India heavily reliant on China for APIs and intermediates, this could lead to higher medicine production costs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/1VbUujE
via IFTTT